Contrary to recent studies, proper use of a drug called aprotinin to reduce bleeding during heart surgery does not increase the risk of heart attack or stroke, according to a study in the June issue of the Journal of Thoracic and Cardiovascular Surgery.
SC@UT is a project designed and developed at the University of Granada which allows autistic children to communicate with people in their environment through a PDA. Thanks to this system, they can express such needs as going to the toilet or hunger and such states as happiness, sadness or tiredness. SC@UT can also be used by adults with cerebral palsy or who cannot speak for different reasons (heart attack, thrombosis, etc.).
Does atherosclerosis result from systemic inflammation, a hallmark of these rheumatic diseases, or from local inflammation of vessels?
Women who regularly enjoy an alcoholic drink or two have a significantly lower risk of having a non-fatal heart attack than women who are life-time abstainers, epidemiologists at the University at Buffalo have shown.
Fish oil supplements are considered good for heart attack patients, and could prevent a repeat attack of survivors of cardiac arrest, MI.
The following is a Statement from the American College of Cardiology, American Diabetes Association and American Heart Association Related to NEJM article, ‘Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes’:
Researchers from the University of Pennsylvania School of Medicine found in a database study of women heart patients that COX inhibitors such as traditional nonsteroidal anti-inflammatory drugs (NSAIDs) may undermine any purported protection against heart disease in participants taking estrogen therapy. The results were described this week in PLoS Medicine.
Evidence confirms Public Citizen?s warnings about the risks of popular diabetes drug Avandia. Statement given by Sidney Wolfe, MD, Director of Health Research Group at Public Citizen:
Any cardio protective effect of hormone replacement therapy may be inhibited if women are taking a particular type of non-steroidal anti-inflammatory pain killer, report researchers led by Garret FitzGerald from University of Pennsylvania in a paper published this week in PLoS Medicine.
The U.S. Food and Drug Administration (FDA) is aware of a potential safety issue related to Avandia (rosiglitazone), a drug approved to treat type 2 diabetes.